Institut Biochimique patents expiration
1. Tirosint patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7691411 | INSTITUT BIOCHIMIQUE | Pharmaceutical formulae for thyroid hormones and procedures for obtaining them |
Mar, 2024
(5 months from now) | |
| US7723390 | INSTITUT BIOCHIMIQUE | Pharmaceutical formulations for thyroid hormones |
Mar, 2024
(5 months from now) | |
Drugs and Companies using LEVOTHYROXINE SODIUM ingredient
Market Authorisation Date: 13 October, 2006
Treatment: NA
Dosage: CAPSULE;ORAL
How can I launch a generic of TIROSINT before it's drug patent expiration?
More Information on Dosage
TIROSINT family patents
2. Tirosint-sol patents expiration
TIROSINT-SOL's oppositions filed in EPO
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US11096913 | INSTITUT BIOCHIMIQUE | High-stability packaged solutions of T4 thyroid hormone |
Feb, 2037
(13 years from now) | |
| US10537538 | INSTITUT BIOCHIMIQUE | High-stability packaged solutions of T4 thyroid hormone |
Feb, 2037
(13 years from now) | |
Drugs and Companies using LEVOTHYROXINE SODIUM ingredient
Market Authorisation Date: 15 December, 2016
Treatment: NA
Dosage: SOLUTION;ORAL
How can I launch a generic of TIROSINT-SOL before it's drug patent expiration?
More Information on Dosage
TIROSINT-SOL family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic